Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer | Oncogene
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase | Nature Communications
APExBIO - Abiraterone|Potent CYP17 inhibitor|CAS# 154229-19-3
APExBIO - TOK-001|CYP17 inhibitor and androgen receptor (AR) antagonist|CAS# 851983-85-2
CYP17 inhibition as a hormonal strategy for prostate cancer | Nature Reviews Urology
Mechanisms of resistance to CYP17 inhibitors. Androgen receptor (AR)... | Download Scientific Diagram
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
CYP17 inhibitors in prostate cancer: latest evidence and clinical potential - Anitha B. Alex, Sumanta K. Pal, Neeraj Agarwal, 2016
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
Drug discovery in advanced prostate cancer: translating biology into therapy | Nature Reviews Drug Discovery
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
Molecules | Free Full-Text | Enzyme Activity of Natural Products on Cytochrome P450
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
The influence of steroid metabolism on CYP17A1 inhibitor activity | Nature Reviews Urology
Resistance to second-generation androgen receptor antagonists in prostate cancer | Nature Reviews Urology
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
Computation | Free Full-Text | Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models
Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 | Nature
ARe we there yet? Understanding androgen receptor signaling in breast cancer | npj Breast Cancer
